Arthrex IRAP II™

Description

There is no bulk discount (buy 5 or more) available on this product anymore as of July 15th, 2021.

Blood processing using the IRAP II device produces serum containing anti-inflammatory and anti-degenerative compounds. The newly designed IRAP II device increases the concentration levels of the beneficial factors in the autologous serum

Arthrex Autologous Blood Processing System (ABPS) consists of a tube containing specially designed glass beads that maximize the surface area inside the tube. Blood that has been incubated in this unique tube can be separated to produce autologous serum useful for treating mild to moderate Osteoarthritis. Because the serum is derived from the animals own blood, the possibility of adverse allergic or anaphylactic side effects is drastically reduced.

The specially designed beads stimulate monocytes to produce regenerative and anti-inflammatory proteins without the addition of drugs. Dual ports provide simplified transfers of blood and removal of therapeutic serum. New color coded ports allow for easy access for the introduction of blood and recovery of serum after incubation and centrifugation. Curved inflow port reduces the risk of hemolysis and increases yield. Unique inflow port directs the blood against the Arthrex ABPS device wall to reduce the damage to the cells.

Autologous blood treatment reduces potential side effects or complications associated with other treatment methods. Blood processed using the Arthrex ABPS device produces serum containing anti-inflammatory and anti-degenerative compounds. The conditioned serum is completely autologous, and contains no drugs.